Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine. The ...
For all investors looking to unearth stocks that are poised to move. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and ...
On a scenic plot near Waddesdon Manor, six high-specification properties have been built. Resolution Homes selected Celotex ...